Autoantibodies in patients with systemic sclerosis and cancer: A case-control study

Journal of Rheumatology

Volumn 30, Issue 9, 2003, Pages 1994-1996

  Derk, Chris T ^c   Sakkas, Lazaros I ^a   Rasheed, Mehmoodur ^b   Artlett, Carol ^d   Jimenez, Sergio A ^d  

^a UNIVERSITY OF THESSALY   (Greece)

^b SAAD SPECIALIST HOSPITAL   (Saudi Arabia)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d NONE

Author keywords

Anticentromere; Autoantibodies; Cancer antitopoisomerase; Systemic sclerosis

Indexed keywords

AUTOANTIBODY;

ADULT; ARTICLE; CANCER; CANCER DIAGNOSIS; CARCINOGENESIS; CHI SQUARE TEST; FEMALE; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC SCLEROSIS;

AGE DISTRIBUTION; AUTOANTIBODIES; CASE-CONTROL STUDIES; COMORBIDITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; NEOPLASMS; PRECANCEROUS CONDITIONS; PROBABILITY; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SCLERODERMA, SYSTEMIC; SEX DISTRIBUTION;

EID: 0041692841     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Seibold JA. Scleroderma. In: Ruddy S, Harris ED, Sledge CB, editors. Textbook of rheumatology. 6th ed. Philadelphia: W.B. Saunders; 2001:1211-40.
2. Clements PJ. Systemic sclerosis (scleroderma) and related disorders: clinical aspects. Baillieres Best Pract Res Clin Rheumatol 2000;14:1-16.
3. Duncan SC, Winkelmann RK. Cancer and scleroderma. Arch Dermatol 1979;115:950-5.
4. Peters-Golden M, Wise RA, Hochberg M, et al. Incidence of lung cancer in systemic sclerosis. J Rheumatol 1985;12:1136-9.
5. Roumm AD, Medsger TA. Cancer and systemic sclerosis: an epidemiological study. Arthritis Rheum 1985;28:1336-40.
6. Abu Shakra M, Guillemin F, Lee P. Cancer in systemic sclerosis. Arthritis Rheum 1993;36:460-4.
7. Rosenthal AK, McLaughlin JK, Gridley G, Nyren O. Incidence of cancer among patients with systemic sclerosis. Cancer 1995;76:910-4.
8. Gruber BL, Miller F, Kauffman LD. Simultaneous onset of systemic sclerosis (scleroderma) and lung cancer: A case report and histologic analysis of fibrogenic peptides. Am J Med 1992;92:705-8.
9. Sakkas LI, Moore DF, Akritidis NC. Cancer in families with systemic sclerosis. Am J Med Sci 1995;310:223-5.
10. Weiner ES, Earnshaw WC, Senecal JL, Bordwell B, Johnson P, Rothfield NF. Clinical associations of anticentromere antibodies and antibodies to topoisomerase I: a study of 355 patients. Arthritis Rheum 1988;31:378-85.
11. Rothfield N, Kurtzman S, Vazques-Abad D, Charron C, Daniels L, Greenberg B. Association of anti-topoisomerase I with cancer [letter]. Arthritis Rheum 1992;35:724.
12. Higuchi M, Horiuchi T, Ishibashi N, Yoshizawa S, Niho Y. Nagasawa K. Anticentromere antibody as a risk factor for cancer in patients with systemic sclerosis. Clin Rheumatol 2000;19:123-6.
13. Kyndt X, Hebbar M, Queyrel V, Hachulla E, Hatron PY, Devulder B. Systemic scleroderma and cancer. Search for predictive factors of cancer in 123 patients with seleroderma. Rev Med Interne 1997;18:528-32.
14. Masi AT, Rodnan GP, Medsger TA Jr, et al. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.